Dr. Cynthia B. Rothschild practices intellectual property law. Dr. Rothschild has worked with a variety of companies and universities to develop their IP portfolios in areas relating to pharmaceuticals, medical devices, chemical compounds, and biotechnology. She is also involved in counseling clients with respect to the development of new technologies, obtaining patent protection for new inventions, as well as providing assessments relating the strength of their IP portfolios and strategies for enforcement of patent rights.

Dr. Rothschild’s professional experience includes serving as a research assistant professor at Wake Forest University Medical School where her research focused on genetic analysis of complex diseases, including cancer and diabetes. In collaboration with a local biotechnology company, Dr. Rothschild developed a highly sensitive assay for detection of genetic changes associated with cancer.

Dr. Rothschild was recognized in 2015 by The Best Lawyers in America® for Biotechnology Law. In 2011, Dr. Rothschild was selected as one of the Triad's Women Extraordinaire by Business Leader Magazine. Dr. Rothschild is very involved with pro bono work, and received the 2002-2003 North Carolina Intellectual Property Section Award for Pro Bono Work. Dr. Rothschild is a former Chair of the North Carolina Bar Association's Intellectual Property Section and remains active in the Section. Additionally, Dr. Rothschild has lectured at Wake Forest University Law School on topics ranging from bioethics to patenting of genetic sequences. She is AV® rated by Martindale-Hubbell.